Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TVTX
TVTX logo

TVTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TVTX News

Travere Therapeutics Director Sells Shares Amid FDA Approval

Apr 20 2026Fool

Travere Therapeutics Secures FDA Approval for Filspari

Apr 20 2026Yahoo Finance

US Stocks Surge as Oil Prices Plunge Amid Ceasefire Talks

Apr 15 2026NASDAQ.COM

Travere Therapeutics Grants Equity Inducements to New Employees

Apr 14 2026Newsfilter

US Stocks Rally as Oil Prices Plunge

Apr 14 2026NASDAQ.COM

US Stocks Rise on Hopes of Iran Ceasefire Negotiations

Apr 14 2026NASDAQ.COM

FDA Approves Filspari for Rare Kidney Disorder Treatment

Apr 14 2026stocktwits

FDA Approves Travere and Ligand's Joint Kidney Disease Therapy Expansion

Apr 14 2026seekingalpha

TVTX Events

04/14 16:20
Major Averages Rise on Renewed U.S.-Iran Diplomacy Optimism
The major averages closed broadly higher as investors shift from escalation fears to tentative optimism around renewed U.S.-Iran diplomacy. Crude slipped back below the $100 level as signals emerge that both sides are considering another round of negotiations, easing immediate supply fears tied to the Strait of Hormuz. The New York Times has reported that Pakistan is seeking to organize a second round of U.S.-Iran talks this week.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:AmazonGlobalstarfor $90 per share in cash or sharesWells Fargoreported, while big bank rivals Citiand JPMorganboth reported upbeat quarterly earnings and revenueJohnson & Johnsonprovided areport for Q1 and raised its quarterly dividend 3.1%CarMaxreported, noting it plans to open four new stores in FY27Microsoftintends tofor its datacenter in Cheyenne, Wyoming in partnership with Black Hills2. WALL STREET CALLS:Teslato Neutral from Sell at UBSDeutsche BankGeneral Motorsto Buy following pullbackFordto Buy from Neutral at UBSGFL Environmentalto Underweight at JPMorganCraig-HallumFastlyto Hold3. AROUND THE WEB:United AirlinesCEO Scott Kirby has floated the idea of a possible tie-up with American Airlines, Bloomberg reportsDelta Airlineshas removed a pair of key environmental sustainability targets from its web page, deleting its pledge to use sustainable aviation fuel for 10% of its jet fuel by 2030 and rephrased its quest to achieve net-zero emissions by 2050 as an "aspiration," not a goal, Bloomberg reportsAnthropic hired Ballard Partners, a lobbying firm with strong ties to the Trump administration days after the DOD designated the startup a supply chain risk, Bloomberg saysNetflix'shostility to cinematic releases has long since damaged its relationships with theater owners, but co-CEO Ted Sarandos is trying to recover them, NY Times saysU.S. President Donald Trump is pitching the idea of a U.S. naval blockade of the Strait of Hormuz as an opportunity for American oil-and-gas exporters, but the squeeze on supplies will likely poorly impact gas prices at the pump, WSJ says4. MOVERS:Avanoswas higher after announcing itby American Industrial Partners for $25.00 per shareTravere Therapeuticsincreased after announcingBloom Energygained afterwith OracleLucidwas lower after, providing guidance for Q1, and announcing $300M stock offeringAdobe, Figma, and GoDaddyall fell after The Informationthat Anthropic is working on an AI design tool5. EARNINGS/GUIDANCE:Rent The Runwayand provided guidance for Q1 and FY26Albertsons, with EPS beating consensusUnity Bancorp, with CEO James Hughes commenting, "We are pleased to report another strong quarter for Unity Bancorp, highlighted by solid profitability"BlackRock, with EPS and revenue beating consensusBlaizeprovidedand backed its guidance for FY26INDEXES:The Dow rose 317.74, or 0.66%, to 48,535.99, the Nasdaq gained 455.35, or 1.96%, to 23,639.08, and the S&P 500 advanced 81.14, or 1.18%, to 6,967.38.
04/14 12:10
Travere Therapeutics Stock Rises 33% to $40.83
Travere Therapeutics is up 33.0%, or $10.13 to $40.83.

TVTX Monitor News

Travere Therapeutics' FILSPARI Receives FDA Approval for FSGS Treatment

Apr 14 2026

Travere Therapeutics Grants RSUs to New Employees

Feb 13 2026

Travere Therapeutics Reports Strong FILSPARI Sales Amid FDA Review

Jan 13 2026

Travere Therapeutics rises amid market strength

Dec 24 2025

TVTX Earnings Analysis

No Data

No Data

People Also Watch